VISUALIZATION OF CHOROIDAL NEOVASCULARIZATION USING TWO COMMERCIALLY AVAILABLE SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY DEVICES.


Journal

Retina (Philadelphia, Pa.)
ISSN: 1539-2864
Titre abrégé: Retina
Pays: United States
ID NLM: 8309919

Informations de publication

Date de publication:
Sep 2019
Historique:
pubmed: 4 8 2018
medline: 28 7 2020
entrez: 4 8 2018
Statut: ppublish

Résumé

To compare the sensitivity of detection and the measured size of choroidal neovascularization (CNV) on two commercially available spectral domain optical coherence tomography angiography (OCTA) devices, the Optovue RTVue XR Avanti with AngioVue and the Zeiss Cirrus HD-OCT with AngioPlex. Patients with CNV lesions were imaged consecutively on both OCTA devices on the same day of their visit. 3 × 3 mm and 6 × 6 mm scans centered at the fovea were obtained. Two independent masked readers evaluated the OCTA images for CNV identification and its area measurements. No significant differences were observed between the 2 OCTA devices in CNV area measurements on their 3 × 3 mm and 6 × 6 mm scans. However, there was suboptimal performance of their automated segmentation algorithms as compared to manually adjusted segmentation for visualizing CNV lesions. There was no significant difference in the size of the CNV lesion as measured on either commercially available spectral domain OCTA device. Both devices were comparable in their detection of CNV lesions on manual adjustment of segmentation lines. However, their automated segmentation algorithms need improvement to allow for accurate measurement of CNV lesions for routine clinical application.

Identifiants

pubmed: 30074522
doi: 10.1097/IAE.0000000000002241
doi:

Types de publication

Comparative Study Evaluation Study Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1682-1692

Auteurs

Malvika Arya (M)

New England Eye Center, Tufts Medical Center, Boston, Massachusetts.

Carl B Rebhun (CB)

New England Eye Center, Tufts Medical Center, Boston, Massachusetts.

Emily D Cole (ED)

New England Eye Center, Tufts Medical Center, Boston, Massachusetts.

Almyr S Sabrosa (AS)

New England Eye Center, Tufts Medical Center, Boston, Massachusetts.
Institute of Ophthalmology, Rio de Janeiro, Brazil.

Gabriel Arcos-Villegas (G)

Hospital Clinico San Carlos, Madrid, Spain.

Ricardo N Louzada (RN)

New England Eye Center, Tufts Medical Center, Boston, Massachusetts.
Federal University of Goiás, Goiânia, Brazil.

Eduardo A Novais (EA)

New England Eye Center, Tufts Medical Center, Boston, Massachusetts.
Federal University of São Paulo, School of Medicine, São Paulo, Brazil.

Mark Lane (M)

New England Eye Center, Tufts Medical Center, Boston, Massachusetts.
Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom.

Sabin Dang (S)

New England Eye Center, Tufts Medical Center, Boston, Massachusetts.

Marcos Ávila (M)

Federal University of Goiás, Goiânia, Goiás, Brazil.

André J Witkin (AJ)

New England Eye Center, Tufts Medical Center, Boston, Massachusetts.

Caroline R Baumal (CR)

New England Eye Center, Tufts Medical Center, Boston, Massachusetts.

Jay S Duker (JS)

New England Eye Center, Tufts Medical Center, Boston, Massachusetts.

Nadia K Waheed (NK)

New England Eye Center, Tufts Medical Center, Boston, Massachusetts.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH